PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
Eotaxin-2/CCL24 19 Target Disease Psoriasis 26,882 1 0.00 -0.97 0.05 0.60
Des (1-6) IGF-II 18 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -0.97 0.06 0.65
Allopurinol (Zyloprim)- FDA 18 Drug Disease Heart Disease 118,291 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
Allopurinol (Zyloprim)- FDA 18 Drug Disease Inflammation 252,734 1 0.00 -0.97 0.06 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.06 0.56
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target Elastase 13,875 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target D(2) Dopamine Receptor 1,559 1 0.01 -0.97 0.06 0.68
BMP-2B 18 Target Target BMP-6 386 1 0.01 -0.97 0.06 0.72
BMP-2B 18 Target Target BMP-7 1,112 2 0.01 -0.94 0.11 0.71
BMP-2B 18 Target Target Collagen 138,882 6 0.00 -0.82 0.33 0.61
BMP-2B 18 Target Target BMP-4 1,255 6 0.04 -0.81 0.33 0.74
BMP-2B 18 Target Target BMP-2 3,889 3 0.01 -0.91 0.17 0.68
BMP-2B 18 Target Target Activin A 2,048 1 0.01 -0.97 0.06 0.67
Des (1-6) IGF-II 18 Target Target Collagen 138,882 1 0.00 -0.97 0.06 0.57
Allopurinol (Zyloprim)- FDA 18 Drug Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Target ERK1 18,374 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Target Collagen 138,882 3 0.00 -0.91 0.17 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
BMP-2B 18 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.06 0.63
Allopurinol (Zyloprim)- FDA 18 Drug Disease Pain 409,851 2 0.00 -0.94 0.11 0.56
Allopurinol (Zyloprim)- FDA 18 Drug Disease Epilepsy 71,172 2 0.00 -0.94 0.11 0.60
Abatacept (Orencia)- FDA 18 Drug Disease Constipation 15,810 1 0.00 -0.97 0.06 0.62
Aldactone (Spironolactone)- FDA 18 Drug Target Aldosterone Receptor 528 1 0.01 -0.97 0.06 0.71
Aldactone (Spironolactone)- FDA 18 Drug Disease Cancer 1,053,491 2 0.00 -0.94 0.11 0.54
Aldactone (Spironolactone)- FDA 18 Drug Disease Depression 220,092 1 0.00 -0.97 0.06 0.56
Aldactone (Spironolactone)- FDA 18 Drug Disease Acne 11,364 4 0.01 -0.88 0.22 0.66
Anesthesia Local 18 Disease Disease Sedation 27,984 2 0.00 -0.94 0.11 0.62
Anesthesia Local 18 Disease Disease Bronchitis 18,336 1 0.00 -0.97 0.06 0.61
Abatacept (Orencia)- FDA 18 Drug Drug Actemra (Tocilizumab Injection)- FDA 2 1 0.17 -0.69 0.50 0.86
Carcinoma Brain 18 Disease Disease Carcinoma 433,099 18 0.01 -0.23 1.00 0.61
Abatacept (Orencia)- FDA 18 Drug Disease Rheumatoid Arthritis 78,952 8 0.01 -0.75 0.44 0.63
Abatacept (Orencia)- FDA 18 Drug Disease Hepatitis 163,842 2 0.00 -0.94 0.11 0.58
Abatacept (Orencia)- FDA 18 Drug Disease Neutropenia 25,934 1 0.00 -0.97 0.06 0.60
Abatacept (Orencia)- FDA 18 Drug Disease Pain 409,851 2 0.00 -0.94 0.11 0.56
Abatacept (Orencia)- FDA 18 Drug Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.06 0.65
Anesthesia Local 18 Disease Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
Anesthesia Local 18 Disease Disease Hemorrhage 100,979 2 0.00 -0.94 0.11 0.59
Anesthesia Local 18 Disease Target CEA 17,022 1 0.00 -0.97 0.06 0.61
Carcinoma Brain 18 Disease Disease Cancer 1,053,491 5 0.00 -0.85 0.28 0.56
Carcinoma Brain 18 Disease Disease Prostate Cancer 71,064 1 0.00 -0.97 0.06 0.58
Carcinoma Brain 18 Disease Disease Lung Carcinoma 13,423 2 0.00 -0.94 0.11 0.64
Anesthesia Local 18 Disease Disease Contraception 21,402 1 0.00 -0.97 0.06 0.61
Abatacept (Orencia)- FDA 18 Drug Disease Inflammation 252,734 2 0.00 -0.94 0.11 0.57